These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20034048)

  • 1. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Neumann-Haefelin C; Timm J; Schmidt J; Kersting N; Fitzmaurice K; Oniangue-Ndza C; Kemper MN; Humphreys I; McKiernan S; Kelleher D; Lohmann V; Bowness P; Huzly D; Rosen HR; Kim AY; Lauer GM; Allen TM; Barnes E; Roggendorf M; Blum HE; Thimme R
    Hepatology; 2010 Jan; 51(1):54-62. PubMed ID: 20034048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.
    Neumann-Haefelin C; Oniangue-Ndza C; Kuntzen T; Schmidt J; Nitschke K; Sidney J; Caillet-Saguy C; Binder M; Kersting N; Kemper MW; Power KA; Ingber S; Reyor LL; Hills-Evans K; Kim AY; Lauer GM; Lohmann V; Sette A; Henn MR; Bressanelli S; Thimme R; Allen TM
    Hepatology; 2011 Oct; 54(4):1157-66. PubMed ID: 22006856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.
    Dazert E; Neumann-Haefelin C; Bressanelli S; Fitzmaurice K; Kort J; Timm J; McKiernan S; Kelleher D; Gruener N; Tavis JE; Rosen HR; Shaw J; Bowness P; Blum HE; Klenerman P; Bartenschlager R; Thimme R
    J Clin Invest; 2009 Feb; 119(2):376-86. PubMed ID: 19139562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.
    Nitschke K; Barriga A; Schmidt J; Timm J; Viazov S; Kuntzen T; Kim AY; Lauer GM; Allen TM; Gaudieri S; Rauch A; Lange CM; Sarrazin C; Eiermann T; Sidney J; Sette A; Thimme R; López D; Neumann-Haefelin C
    J Hepatol; 2014 Jan; 60(1):22-9. PubMed ID: 23978718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.
    Schmidt J; Iversen AK; Tenzer S; Gostick E; Price DA; Lohmann V; Distler U; Bowness P; Schild H; Blum HE; Klenerman P; Neumann-Haefelin C; Thimme R
    PLoS Pathog; 2012; 8(11):e1003042. PubMed ID: 23209413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?
    Neumann-Haefelin C
    Curr Opin Rheumatol; 2013 Jul; 25(4):426-33. PubMed ID: 23656712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes.
    Ziegler S; Ruhl M; Tenckhoff H; Wiese M; Heinemann FM; Horn PA; Spengler U; Neumann-Haefelin C; Nattermann J; Timm J;
    J Hepatol; 2013 Jan; 58(1):24-30. PubMed ID: 22925811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERAP1 allotypes shape the epitope repertoire of virus-specific CD8
    Kemming J; Reeves E; Nitschke K; Widmeier V; Emmerich F; Hermle T; Gostick E; Walker A; Timm J; Price DA; Hofmann M; Thimme R; James E; Neumann-Haefelin C
    J Hepatol; 2019 Jun; 70(6):1072-1081. PubMed ID: 30769005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Immunodominance Hierarchy of CD8
    Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
    Ruhl M; Chhatwal P; Strathmann H; Kuntzen T; Bankwitz D; Skibbe K; Walker A; Heinemann FM; Horn PA; Allen TM; Hoffmann D; Pietschmann T; Timm J
    J Virol; 2012 Jan; 86(2):991-1000. PubMed ID: 22072759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective role of HLA-B27 in HIV and hepatitis C virus infection].
    Neumann-Haefelin C
    Dtsch Med Wochenschr; 2011 Feb; 136(7):320-4. PubMed ID: 21302207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
    Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
    J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.
    Salloum S; Oniangue-Ndza C; Neumann-Haefelin C; Hudson L; Giugliano S; aus dem Siepen M; Nattermann J; Spengler U; Lauer GM; Wiese M; Klenerman P; Bright H; Scherbaum N; Thimme R; Roggendorf M; Viazov S; Timm J
    J Virol; 2008 Dec; 82(23):11803-12. PubMed ID: 18815309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of Unique Hepatitis C Virus-Specific Public CD8
    Mazouz S; Boisvert M; Abdel-Hakeem MS; Khedr O; Bruneau J; Shoukry NH
    J Immunol; 2021 Aug; 207(4):1180-1193. PubMed ID: 34341170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.
    Fitzmaurice K; Petrovic D; Ramamurthy N; Simmons R; Merani S; Gaudieri S; Sims S; Dempsey E; Freitas E; Lea S; McKiernan S; Norris S; Long A; Kelleher D; Klenerman P
    Gut; 2011 Nov; 60(11):1563-71. PubMed ID: 21551190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.